Growth Metrics

Dna X (SONM) Receivables - Net (2018 - 2025)

Dna X filings provide 8 years of Receivables - Net readings, the most recent being $3.5 million for Q3 2025.

  • On a quarterly basis, Receivables - Net fell 33.24% to $3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.5 million, a 33.24% decrease, with the full-year FY2024 number at $4.3 million, down 82.85% from a year prior.
  • Receivables - Net hit $3.5 million in Q3 2025 for Dna X, up from $2.9 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $30.3 million in Q3 2023 to a low of $2.9 million in Q2 2025.
  • Median Receivables - Net over the past 5 years was $10.4 million (2022), compared with a mean of $12.7 million.
  • Biggest five-year swings in Receivables - Net: soared 418.89% in 2023 and later crashed 82.85% in 2024.
  • Dna X's Receivables - Net stood at $13.1 million in 2021, then soared by 71.8% to $22.4 million in 2022, then rose by 12.8% to $25.3 million in 2023, then crashed by 82.85% to $4.3 million in 2024, then fell by 19.38% to $3.5 million in 2025.
  • The last three reported values for Receivables - Net were $3.5 million (Q3 2025), $2.9 million (Q2 2025), and $4.8 million (Q1 2025) per Business Quant data.